Latest Breaking News On - Anne kathrin klebl - Page 1 : comparemela.com

With the funding, CasInvent Pharma will be strengthening its portfolio of CK1 inhibitors and progressing its lead compound to the development candidate status.

Czech republicKamil paruchMichael krebsCasinvent pharmaRadoslav trautmannMartin kovalAnne kathrin kleblIvan vohlmuthPeter nussbaumerAlexander scheerTechnology transfer officeMasaryk universityBiotech fundHead of technology transfer departmentTechnology transfer fundInvent pharma